Skip to content
10-Q/A

Quarterly Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-13-000008

← back to feed
Filed
May 8, 2013 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Apr 17, 2013 111.55M sh
Operating Cash Flow Q3 2013 · Mar 31, 2013 −$48.58K
Operating Cash Flow Q3 2013 · Mar 31, 2013 −$163.06K
Operating Cash Flow Q3 2013 · Mar 31, 2013 −$2.04M
Operating Cash Flow Q3 2013 · Mar 31, 2012 −$31.39K
Operating Cash Flow Q3 2013 · Mar 31, 2012 −$123.37K
Cash And Equivalents Q3 2013 · Mar 31, 2013 $13.12K
Cash And Equivalents Q3 2013 · Jun 30, 2012 $2.57K
Stockholders Equity Q3 2013 · Mar 31, 2013 −$2.27M
Stockholders Equity Q3 2013 · Jun 30, 2012 −$2.08M
Total Liabilities Q3 2013 · Mar 31, 2013 $2.29M
Total Liabilities Q3 2013 · Jun 30, 2012 $2.09M
Current Assets Q3 2013 · Mar 31, 2013 $17.61K
Current Assets Q3 2013 · Jun 30, 2012 $8.84K
Net Income Q3 2013 · Mar 31, 2013 −$51.6K
Net Income Q3 2013 · Mar 31, 2013 −$152.59K
Net Income Q3 2013 · Mar 31, 2013 −$2M
Net Income Q3 2013 · Mar 31, 2012 −$30.81K
Net Income Q3 2013 · Mar 31, 2012 −$112.55K
Operating Income Q3 2013 · Mar 31, 2013 −$51.6K
Operating Income Q3 2013 · Mar 31, 2013 −$151.77K
Operating Income Q3 2013 · Mar 31, 2013 −$2.29M
Operating Income Q3 2013 · Mar 31, 2012 −$30.81K
Operating Income Q3 2013 · Mar 31, 2012 −$112.55K